BioLineRx Ltd. logo

BioLineRx Ltd.

BLRX | NASDAQ
Chart Builder DCF Calculator
$2.48
-$0.01 (-0.28%)
At close: Sep 21, 2026, 4:00 PM ET
$2.49
+$0.01 (+0.40%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$10.79M
Enterprise Value
$5.65M
Beta
0.70
Average Volume
41.9K
Shares Outstanding (Diluted)
4.44M
Shares Change YoY
12.45%
Institutional Ownership
0.44%
Exchange
NASDAQ
ISIN
US09071M3043

Price Performance

Price Change 1M
-18.4%
Price Change 3M
-23.9%
Price Change 6M
4.2%
Price Change YTD
-11.4%
Price Change 1Y
-35.9%
Price Change 3Y
-97.0%
Price Change 5Y
-97.9%
1M CAGR (ann.)
-8.5%
1Y CAGR (ann.)
-35.9%
5Y CAGR (ann.)
-53.5%
All-Time CAGR
-37.8%

Valuation

PE Ratio
-1.38
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.07
PS Ratio
7.72
Forward PS
4.90
PB Ratio
0.78
P/FCF Ratio
-0.99
P/Adj. FCF Ratio
-0.97
P/OCF Ratio
-41.33
EV/Sales
4.04
EV/EBIT
-0.66
EV/EBITDA
-0.68
EV/FCF
-0.52
Earnings Yield
-72.6%
FCF Yield
-101.0%
Adj. FCF Yield
-102.7%

Financial Health

Net Cash
$6.1M
Total Debt
$7.94M
Cash & Short-Term Investments
$13.08M
Total Assets
$33.48M
Current Ratio
1.20
Quick Ratio
1.04
Debt / Equity Ratio
0.58
Debt / EBITDA
-0.96
Debt / FCF
-0.73
OCF / Debt
-1.37
Interest Coverage
-11.65
Altman Z-Score
-17.29
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
70.0%
Operating Profit Margin
-876.3%
EBITDA Margin
-808.9%
Net Profit Margin
-575.8%
FCF Margin
-779.6%
Adj. FCF Margin
-792.5%
SBC / Revenue
16.3%
SBC Impact (per share)
-1.6%

Returns

Return on Assets
-24.2%
Return on Equity
-47.2%
Return on Invested Capital
-50.1%
Return on Capital Employed
-62.2%
Return on Tangible Assets
-47.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
-65.8%
Revenue CAGR 5Y
28.1%
Revenue CAGR 10Y
37.1%
EPS CAGR 3Y
106.9%
EPS CAGR 5Y
41.6%
EPS CAGR 10Y
30.4%
FCF CAGR 3Y
46.9%
FCF CAGR 5Y
14.7%
FCF CAGR 10Y
2.3%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
22.2%
Revenue Growth Next 3Y
74.2%
Earnings Date
Nov 22, 2026
EPS Estimate (next Q)
-$0.39
EPS Growth Est (next Q)
77.3%
Revenue Est (next Q)
$357.5K
Revenue Growth Est (next Q)
-16.3%

Cash Flow

Operating Cash Flow
$-10.88M
Free Cash Flow
$-10.9M
Adj. Free Cash Flow
$-11.08M
FCF Per Share
-$0.06
OCF Per Share
-$0.06
OCF/S Ratio
-783.7%

Income Statement

Revenue
$1.4M
Gross Profit
$976.26K
Operating Income
$-12.25M
EBITDA
$-8.26M
Net Income
$-8.03M
EPS (Diluted)
-$1.80
Revenue / Employee
$63.56K
Profit / Employee
$-364.98K
Employees
22

© 2026 bestshares.com. All rights reserved.